 | CARE - Metro Healthcare Indonesia Tbk. | CARE - Metro Healthcare Indonesia Tbk. | CARE - Metro Healthcare Indonesia Tbk. | |
| Sector | : | Healthcare | ||
| Sub Sector | : | Healthcare Equipment and Providers | ||
| Industry | : | Healthcare Providers | ||
| Sub Industry | : | Healthcare Providers | ||
| Index (5) | : | IDXHEALTH, IDXSMC-COM, ISSI, COMPOSITE, DBX | ||
| Index (5) | : | IDXHEALTH, IDXSMC-COM, ISSI, COMPOSITE, DBX | ||
| Board | : | 5 Index IDXHEALTH, IDXSMC-COM, ISSI, COMPOSITE, DBX | ||
| Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
| Corporate Action | : | - | ||
| RATING & BTO MATRIX | ||||||
|---|---|---|---|---|---|---|
| Benchmark to Others : | ||||||
| A Exceptional | ||||||
| B Excellent | ||||||
| C Very Good | ||||||
| D Good | ||||||
| E Fair | ||||||
| F Poor | |
|||||
| RATING | ||||||
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING FUNDAMENTAL | ||
|---|---|---|
| Rating EPS | 0 | |
| Rating ROA | 0 | |
| Rating EQUITY | 1 | |
| Rating ROE | 0 | |
| Rating DER | 5 | |
| Rating TOTAL | 1 | |
| MARKET CAPITALIZATION | ||
| Listed Share | 33.250.000.000 | |
| Price | Rp. 102 | |
| Capitalization | Rp. 3.391.500.000.000 | |
| OWNERSHIP | ||
| Listing Date : 13-MAR-2020 | ||
| Lokal 60,73 % | Asing 26,94 % | Lainnya 12,33 % |
| CARE - Metro Healthcare Indonesia Tbk. | CARE - Metro Healthcare Indonesia Tbk. | CARE - Metro Healthcare Indonesia Tbk. | |
| Sector | : | Healthcare | ||
| Sub Sector | : | Healthcare Equipment and Providers | ||
| Industry | : | Healthcare Providers | ||
| Sub Industry | : | Healthcare Providers | ||
| Index (5) | : | IDXHEALTH, IDXSMC-COM, ISSI, COMPOSITE, DBX | ||
| Index (5) | : | IDXHEALTH, IDXSMC-COM, ISSI, COMPOSITE, DBX | ||
| Board | : | 5 Index IDXHEALTH, IDXSMC-COM, ISSI, COMPOSITE, DBX | ||
| Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
| Corporate Action | : | - | ||
Financial Statements
| Description | 2Q20 | 2Q21 | 2Q22 | 2Q23 | 2Q24 | CAGR 5Y(%) | ||
| Last Price | 320 | 350 | 500 | 468 | 81 | |||
| Market Cap | 10.6 T | 11.6 T | 16.6 T | 15.6 T | 2.7 T | -74.53 | ||
| BALANCE SHEET | ||||||||
| Cash | 1.2 T | 614.5 B | 1.1 T | 810.2 B | 673.9 B | -43.84 | ||
| Total Asset | 3.4 T | 3.5 T | 4.2 T | 4.2 T | 4.1 T | 20.59 | ||
| S.T.Borrowing | 42.5 B | 61.6 B | 72.5 B | 224.7 B | 880.0 B | |||
| L.T.Borrowing | 106.5 B | 105.0 B | 833.8 B | 802.1 B | 123.1 B | |||
| Total Equity | 3.3 T | 3.3 T | 3.2 T | 3.2 T | 3.1 T | -6.06 | ||
| INCOME STATEMENT | ||||||||
| Revenue | 104.4 B | 146.3 B | 112.7 B | 106.8 B | 165.5 B | 58.52 | ||
| Gross Profit | 49.9 B | 79.6 B | 46.7 B | 48.6 B | 52.3 B | 4.81 | ||
| Operating Profit | -4.8 B | 16.4 B | -30.0 B | -7.2 B | -11.1 B | 131.25 | ||
| Net.Profit | 6.3 B | 15.7 B | -51.7 B | -40.1 B | -45.4 B | -820.63 | ||
| EBITDA | 1.1 B | 23.2 B | -18.9 B | 3.5 B | 540.2 M | -50.89 | ||
| Interest Expense | 5.8 B | 6.1 B | 42.1 B | 35.9 B | 36.6 B | |||
| RATIO | ||||||||
| EPS | 0.19 | 0.47 | -1.55 | -1.21 | -1.36 | -815.79 | ||
| PER | 1,684.21 x | 744.68 x | -322.58 x | -386.78 x | -59.56 x | |||
| BVPS | 98.73 | 99.45 | 97.63 | 95.24 | 91.8 | |||
| PBV | 3.24 x | 3.52 x | 5.12 x | 4.91 x | 0.88 x | |||
| ROA | 0.0018 | 0.0045 | -0.0125 | -0.0096 | -0.0112 | -722.22 | ||
| ROE | 0.0019 | 0.0048 | -0.0159 | -0.0127 | -0.0149 | -884.21 | ||
| EV/EBITDA | 9054.82 | 482.86 | -867.48 | 4531.06 | 5594.94 | |||
| Debt/Equity | 0.05 | 0.05 | 0.28 | 0.32 | 0.33 | |||
| Debt/TotalCap | 0.04 | 0.05 | 0.22 | 0.24 | 0.25 | |||
| Debt/EBITDA | 140.79 | 7.19 | -47.89 | 294.88 | 1856.94 | |||
| EBITDA/IntExps | 0.18 | 3.77 | -0.45 | 0.1 | 0.01 | -94.44 | ||
| RATING & BTO MATRIX | ||||||
|---|---|---|---|---|---|---|
| Benchmark to Others : | ||||||
| A Exceptional | ||||||
| B Excellent | ||||||
| C Very Good | ||||||
| D Good | ||||||
| E Fair | ||||||
| F Poor | |
|||||
| RATING | ||||||
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| MARKET CAPITALIZATION | ||
| Listed Share | 33.250.000.000 | |
| Price | Rp. 102 | |
| Capitalization | Rp. 3.392 B. | |
| OWNERSHIP | ||
| Listing Date : 13-MAR-2020 | ||
| Lokal 60,73 % | Asing 26,94 % | Lainnya 12,33 % |
| RATING FUNDAMENTAL | ||
|---|---|---|
| Rating EPS | 0 | |
| Rating ROA | 0 | |
| Rating EQUITY | 1 | |
| Rating ROE | 0 | |
| Rating DER | 5 | |
| Rating TOTAL | 1 | |
EARNING PER SHARE
| CARE - Metro Healthcare Indonesia Tbk. | CARE - Metro Healthcare Indonesia Tbk. | CARE - Metro Healthcare Indonesia Tbk. | |
| Sector | : | Healthcare | ||
| Sub Sector | : | Healthcare Equipment and Providers | ||
| Industry | : | Healthcare Providers | ||
| Sub Industry | : | Healthcare Providers | ||
| Index (5) | : | IDXHEALTH, IDXSMC-COM, ISSI, COMPOSITE, DBX | ||
| Index (5) | : | IDXHEALTH, IDXSMC-COM, ISSI, COMPOSITE, DBX | ||
| Board | : | 5 Index IDXHEALTH, IDXSMC-COM, ISSI, COMPOSITE, DBX | ||
| Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
| Corporate Action | : | - | ||
| TIME PERIOD : 10-10-2024 | |||
| Close | 102 | Prev Close | 105 |
| Change | -3 (-2.9%) | Range | 99-107 |
| Bid | 102 | Offer | 103 |
| Bid Volume | 131000 | Offer Volume | 768000 |
| Frequency | 2143 | Value Rp.: 5.375.487.500 | |
| EARNING PER SHARE (% PRICE) | |||||
|---|---|---|---|---|---|
| Benchmark to Others : | |||||
| A Exceptional | |||||
| B Excellent | |||||
| C Very Good | |||||
| D Good | |||||
| E Fair | |||||
| F Poor | |
||||
| Percent (%) of Price |
≤ 0 |
0-1.05 | 1.05-2.3 | 2.3-4.23 | > 4.23 |
| RATING & BTO MATRIX | ||||||
|---|---|---|---|---|---|---|
| Benchmark to Others : | ||||||
| A Exceptional | ||||||
| B Excellent | ||||||
| C Very Good | ||||||
| D Good | ||||||
| E Fair | ||||||
| F Poor | |
|||||
| RATING | ||||||
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
